Exchange: NASDAQ·Updated 07:55 PM EDT
PLUR logo

PLUR Pluri Inc

$1.27
$0.09
(6.62%)
Today
Closed $1.27
$0.01
(0.79%)
After Hours
Mkt Cap$16.79M
Vol17,555.00

About PLUR

Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
34

Bearish Sentiment

How do you feel about PLUR?

Advertisement|Remove ads.